Search for: "NOVARTIS PHARMACEUTICALS CORP." Results 281 - 300 of 367
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
25 Feb 2011, 1:26 pm by Christa Culver
KuzinskiDocket: 10-459Issue(s): (1) What deference is due to an agency interpretation of its own regulations when the interpretation departs from the agency’s prior position; and (2) whether the Second Circuit erred in its construction of the outside sales exemption of the Fair Labor Standards Act.Certiorari stage documents:Opinion below (2d Cir.)Petition for certiorariBrief in oppositionPetitioner's reply Title: Novartis Pharmaceuticals Corp. v. [read post]
3 Mar 2020, 4:00 am by Alan Macek
In Novartis Pharmaceuticals Canada Inc. v. [read post]
31 Dec 2010, 11:31 am by Bexis
Novartis Pharmaceuticals Corp., DA 10-0029  slip op., at 30 (Mont. [read post]
27 May 2009, 5:27 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: [duncanbucknell.com]   Highlights this week included: Pfizer acquires rights to 55 generic pills, 20 injectibles through new deals with Claris Lifesciences and Aurobindo (GenericsWeb) Sytrinol (Polymethoxylated flavones, tocotrienols) – US: District Court N D Illinois rules patent co-owned by US not immunised from infringement or validity determinations (Patent Docs)   General… [read post]
19 Jun 2007, 9:44 am
Also, Qualcomm was a signer, as were WARF, Cornell University, Monsanto, and Novartis. [read post]
25 Jan 2008, 1:00 am
: (Generic Pharmaceuticals & IP),Arava (Leflunomide) - Sanofi-Aventis loses bid to dismiss Louisiana Wholsesale Drug Co's antitrust claims accusing S-A of unlawfully blocking generic competition for Arava by filing a sham Citizen Petition with the USFDA: (IP Law360),Ciprofloxacin - CIPLA issued notice by National Pharmaceutical Pricing Authority for allegedly overpricing its antibiotic Ciprofloxacin (especially of note because CIPLA … [read post]
22 Aug 2014, 9:22 am
Novartis Pharmaceutical Corp., 2013 WL 4648449 (M.D. [read post]
15 Feb 2008, 9:00 am
A step behind: (Spicy IP),Proposals for ISPs to terminate infringers go (even more) global: (LawFont.com),Five ways to minimize risk of copyright liability from citizen media: (IP ADR Blog), Pharma & BiotechPharma & Biotech - GeneralMillennium Pharmaceuticals spent $1.28 million on lobbying for patent reform and biologics legislation in 2007: (Patent Docs),New Thai Minister may review compulsory licences on cancer drugs: (Intellectual Property… [read post]
18 Oct 2007, 10:33 pm
A long time ago - blogwise, anyway - we put together a post that described and linked to all the FDA's amicus curiae briefs that the Agency had filed in favor of preemption in prescription drug and medical device product liability litigation. [read post]
7 Jan 2010, 10:36 am by Beck, et al.
American Home Products Corp., 2004 WL 2095451 (E.D. [read post]
22 Sep 2022, 9:54 am by Holly Brezee
Most recently, Novartis AG plans to appeal a case to the U.S. [read post]